recent outbreak human air ebolaviru erov spider spiral control west africa hemorrhage fever case fatal rate classify biosafeti level pathogen consider category agent bioterror center disease prevent approve therapy vaccine avail treatment apart support care although sever promise therapeutic agent undergo phase trial current might output speed drug product like virus lang reli host cell factor physiology process entry replica press review current shown effect suppress provider culture anim studi review direct nonmut target indeed viral mutant medic food drug administer fda disease stockpile immer use may also complementary role develop metal electron supplementary mater online version article doi contain author user 